10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBOTT LABORATORIES | |||
Ticker: ABT Fiscal Year: 2020 | |||
Consolidated Statement of Earnings | |||
Period Ending Dec 31, 2020 10-K (Filed: Feb 19, 2021) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
| Net sales | $ 34,608 | 31,904 | 30,578 |
| Cost of products sold, excluding amortization of intangible assets | 15,003 | 13,231 | 12,706 |
| Amortization of intangible assets | 2,132 | 1,936 | 2,178 |
| Research and development | 2,420 | 2,440 | 2,300 |
| Selling, general and administrative | 9,696 | 9,765 | 9,744 |
| Total Operating Cost and Expenses | 29,251 | 27,372 | 26,928 |
| Operating Earnings | 5,357 | 4,532 | 3,650 |
| Interest expense | 546 | 670 | 826 |
| Interest income | (46) | (94) | (105) |
| Net foreign exchange (gain) loss | (8) | 7 | 28 |
| Debt extinguishment costs | 63 | 167 | |
| Other (income) expense, net | (103) | (191) | (139) |
| Earnings from Continuing Operations Before Taxes | 4,968 | 4,077 | 2,873 |
| Taxes on Earnings from Continuing Operations | 497 | 390 | 539 |
| Earnings from Continuing Operations | 4,471 | 3,687 | 2,334 |
| Net Earnings from Discontinued Operations, net of taxes | 24 | 34 | |
| Net Earnings | 4,495 | 3,687 | 2,368 |
| Basic Earnings Per Common Share -- | |||
| Continuing Operations | 2.51 | 2.07 | 1.32 |
| Discontinued Operations | 0.01 | 0.02 | |
| Net Earnings | 2.52 | 2.07 | 1.34 |
| Diluted Earnings Per Common Share -- | |||
| Continuing Operations | 2.49 | 2.06 | 1.31 |
| Discontinued Operations | 0.01 | 0.02 | |
| Net Earnings | 2.50 | 2.06 | 1.33 |
| Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share | 1,773 | 1,768 | 1,758 |
| Dilutive Common Stock Options | 13 | 13 | 12 |
| Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options | 1,786 | 1,781 | 1,770 |
| Outstanding Common Stock Options Having No Dilutive Effect | 9 | 61 | |
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2020 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |